Lung Transplant Rejection: Clinical Trials

9 trials for Lung Transplant Rejection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 terminated, 1 recruiting, 1 unknown. 9 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 29Completed 3, Terminated 3, Recruiting 1, Unknown 1, Withdrawn 1
Phase 11Unknown 1

Follow Lung Transplant Rejection: new trials by email Literature Review of Lung Transplant Rejection trials Research Report on Lung Transplant Rejection

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
HP 129Xe MRI for Evaluation of CLAD in Lung Transplant Recipients
129Xenon - Lung Transplant Rejection
Phase 2TerminatedThe Hospital for Sick Children62024-02-072025-09-04
An Open Label Trial Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetic Profile of Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients
Tacrolimus Inhalation Powder, Plastiape RS00 Dry Powder inhaler device - Lung Transplant Rejection
Phase 2TerminatedTFF Pharmaceuticals, Inc.142023-04-182025-01-06
Adipose Derived Mesenchymal Cell Treatment in Lungtransplantation
adipose derived mesenchymal stromal cells, Saline - Lung Transplant Rejection
Phase 1 / Phase 2UnknownCopenhagen University Hospital, Rigshospitalet302020-10-012021-07-16
Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation
Belatacept, Tacrolimus, ATG - Lung Transplant Rejection, Antibody-mediated Rejection
Phase 2CompletedWashington University School of Medicine272019-12-172022-11-25
Lung Transplant Plasmapheresis/Belatacept/Carfilzomib for Antibody Mediated Rejection and Desensitization
Belatacept, Carfilzomib - Lung Transplant Rejection, Antibody-mediated Rejection
Phase 2WithdrawnDuke University2019-05-012019-05-02
Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection
Sub study (Active): Two Lung MRI study with two navigational Bronchoscopy, Hyperpolarized Xenon129 - Lung Transplant Rejection
Phase 2RecruitingUniversity of Virginia602019-04-012026-03-17
Pirfenidone for Restrictive Chronic Lung Allograft Dysfunction
Pirfenidone - Restrictive Chronic Lung Allograft Dysfunction, Lung Transplant Rejection
Phase 2CompletedUniversity of California, San Francisco102018-03-072023-06-29
Combination Therapy With Carfilzomib for the Antibody-Mediated Rejection Diagnosis in Lung Transplantation
Carfilzomib - Lung Transplant Rejection
Phase 2CompletedJohn F. McDyer, MD222015-11-012022-04-25
Prospective Study for Transplant Optimization Using Functional Imaging (TROFI)
HRCT scans - Bronchiolitis Obliterans, Lung Transplant Rejection
Phase 2TerminatedFLUIDDA nv102015-07-012018-03-21

Narrower conditions

Bronchiolitis Obliterans (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Rejection, Psychology (1)

Broader conditions

Behavior (1)  ·  Bronchial Diseases (1)  ·  Bronchiolitis (1)  ·  Bronchitis (1)  ·  Graft vs Host Disease (1)  ·  Immune System Diseases (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Obstructive (1)  ·  Organizing Pneumonia (1)  ·  Respiratory Tract Diseases (1)  ·  Social Behavior (1)

Interventions

Abatacept (2)  ·  Tacrolimus (2)  ·  carfilzomib (2)  ·  Methylprednisolone (1)  ·  Methylprednisolone Hemisuccinate (1)  ·  Mycophenolic Acid (1)  ·  Prednisone (1)  ·  Sodium Chloride (1)  ·  pirfenidone (1)  ·  thymoglobulin (1)

Sponsors

Copenhagen University Hospital, Rigshospitalet (1)  ·  Duke University (1)  ·  FLUIDDA nv (1)  ·  John F. McDyer, MD (1)  ·  TFF Pharmaceuticals, Inc. (1)  ·  The Hospital for Sick Children (1)  ·  University of California, San Francisco (1)  ·  University of Virginia (1)  ·  Washington University School of Medicine (1)

Countries

United States (4)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  Denmark (1)

Top investigators

Aida A Venado Estrada, MD (1)  ·  Giles Santyr, PhD (1)  ·  Jens Kastrup, MD Professor (1)  ·  John McDyer, MD (1)  ·  Laurie Snyder (1)  ·  Michael Perch, MD (1)  ·  Ramsey R Hachem, MD (1)  ·  Wilfried De Backer, M.D., M.S. (1)  ·  Yun M Shim, MD (1)  ·  Zamaneh Mikhak, MD (1)

Results publications

PMID 37899481, PMID 40247997

NIH funding

R01HL173369 (1)